利用生物标志物通过bcl2表达的调节治疗癌症的方法

Methods of using biomarkers for the treatment of cancer by modulation of BCL2 expression

Abstract

The present invention relates to cancer therapies and methods of using the same. In particular, the present invention provides methods of monitoring and improving the administration of cancer therapies, wherein the cancer is mediated by the BCL2 oncogene, via markers of disease identification, disease progression, drug resistance, and/or treatment efficacy.
本发明涉及癌症的疗法和使用它们的方法。特别地,本发明提供了通过疾病鉴别、疾病进展、耐药性和/或治疗效果的标志物监控和改善癌症疗法施用的方法,其中所述癌症是由BCL2致癌基因介导的。

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (1)

    Publication numberPublication dateAssigneeTitle
    CN-105296656-AFebruary 03, 2016北京泱深生物信息技术有限公司一种诊治鼻咽癌的分子标志物